新闻
RDHL
--
0.00%
--
RedHill Biopharma 强调管理层最近购买的 ADS
RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members of its board of directors and senior management, including the
Benzinga · 13小时前
RedHill Biopharma Ltd 宣布将 Talicia(R) 添加到 Medi-Cal CDL
RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements Addition of Talicia® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no
Benzinga · 10/06 11:04
RedHill Biopharma 的 Talicia® 加入 Medi-Cal 合同药品清单,无需事先授权
and , /PRNewswire/ --  (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Medi-Cal - Medicaid Health Care program covering two million patients - has added Talicia (omeprazole magnesium, amoxicillin a...
PR Newswire - PRF · 10/06 11:00
RedHill (RDHL) COVID 肺炎药物达到研究目标,库存充足
Zacks.com · 10/05 15:40
16 只股票在周二的盘前交易时段内波动
Gainers Marine Petroleum Trust (NASDAQ: MARPS) rose 25.4% to $6.29 in pre-market trading after gaining 8% on Monday.
Benzinga · 10/05 11:07
为什么 RedHill Biopharma 股价周一上涨 12%?
Benzinga · 10/04 21:30
30 只股票在周一的中盘交易
Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.
Benzinga · 10/04 16:06
在 Covid 治疗试验取得进展后,RedHill 股价走高
RedHill Biopharma rose after the company reported progress in a study of its Covid drug for severely ill and hospitalized patients.
TheStreet.com · 10/04 14:33
RedHill Biopharma 报告了对 2/3 期数据的进一步分析,包括在中等严重程度的 COVID-19 患者中口服 Opaganib 使死亡率降低 62%
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported new data from the opaganib global Phase 2/3 study in hospitalized patients with severe COVID-19 pneumonia showing that treatment with ...
PR Newswire · 10/04 12:00
RedHill Biopharma 申请美国专利“用于治疗冠状病毒感染的丝氨酸蛋白酶抑制剂”
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=8117&p=163&f=G&l=50&d=PG01&S1=20210930.PD.&OS=PD/20210930&RS=PD/20210930
Benzinga · 09/30 13:43
来自 BZ 的小型医疗保健会议:RedHill Biopharma 首席业务官 Guy Goldberg 开始演讲
Click To Tune In Here... https://www.youtube.com/watch?v=TG5SSZDlpBo
Click To Tune In Here...  · 09/30 13:30
TENX:第二季度业绩
By John Vandermosten, CFA NASDAQ:TENX READ THE FULL TENX RESEARCH REPORT
Benzinga · 09/25 15:21
简报-RedHill Biopharma 与 Aurobindo 就 Movantik 专利诉讼达成和解
reuters.com · 09/23 11:17
RedHill Biopharma 宣布与 Aurobindo 达成和解 Movantik®专利诉讼
and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AstraZeneca AB and AstraZeneca Pharmaceuticals LP ("AstraZeneca") and Nektar Therapeutics have entered ...
PR Newswire - PRF · 09/23 11:00
RedHill (RDHL) 对 COVID-19 研究的数据不满意
RedHill (RDHL) posts preliminary top-line data from a phase II/III study evaluating opaganib in hospitalized patients with severe COVID-19 pneumonia. Stocks falls as the study fails to achieve its goal.
Zacks · 09/15 15:40
HC Wainwright & Co. 维持对 Redhill Biopharma 的买入,将目标价下调至 21 美元
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Redhill Biopharma (NASDAQ:RDHL) with a Buy and lowers the price target from $23 to $21.
Benzinga · 09/15 10:08
HC Wainwright 将 Redhill Biopharma 的目标价格从 23 美元下调至 21 美元,维持买入评级
MT Newswires · 09/15 07:42
热门股票:澳门赌局; FCEL 收益; CROX 命中率高; WEBR 设置低; RDHL 的临床数据下降
While state governments in the U.S. have largely loosened restrictions on gambling in recent years, there are reports that Macau might be taking the opposite approach. Speculation of stepped-up oversight
Seekingalpha · 09/14 21:56
微牛提供丰富的实时RDHL股票新闻,让你可以通过多个平台了解RDHL股票行情最新动态,这些免费的Redhill Biopharm新闻可以帮助你做出明智投资。
RDHL 简况
Redhill Biopharma Ltd是一家以色列的专业生物制药公司,主要专注于胃肠道疾病和传染病业务。该公司在美国推广三种胃肠道药物:Movantik、Talicia和Aemcolo。关键临床后期产品线开发计划包括:opaganib(Yeliva)和用于多种适应症的RHB-107,包括COVID-19、RHB-204肺部非结核分枝杆菌(NTM)病和RHB-104克罗恩病。